ID
IDEXX Laboratories
IDXX·NASDAQWestbrook MEFounded 198311,000 employees
Large CapbiotechPublicOncology
Platform: Vet Diagnostics
Market Cap
$40B
All Drugs
9
Clinical Trials
17
Failed / Terminated
3
FDA Approved
2
Stock Price & Catalysts (IDXX)
Loading IDXX stock data...
Drug Pipeline (9 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| IDX-6209 | IDX-6209 | Preclinical | 2 | CGRP | CRC | ||
| Miriglumide | IDX-7883 | NDA/BLA | 2 | PARP | IPFNMOSD | ||
| Miriosocimab | IDX-938 | Approved | 4 | DLL3 | Pompe | ||
| Gozeinavolisib | IDX-6711 | Phase 2/3 | 2 | USP1 | Cholangiocarcinoma | ||
| Mavufotisoran | IDX-7808 | Approved | 2 | SMN2 | RBHS | ||
| Fixatinib | IDX-2219 | Phase 2/3 | 1 | PD-L1 | IPFGIST | ||
| Sotovorutinib | IDX-6158 | Phase 1/2 | 2 | AuroraA | Melanoma | ||
| Gelibrutinib | IDX-128 | NDA/BLA | 1 | WRN | Endometrial Ca | ||
| IDX-785 | IDX-785 | Phase 1 | 1 | AHR | Crohn's |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (13)